Results 141 to 150 of about 24,005 (199)

AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models. [PDF]

Commun Med (Lond)
Novak R, Lin T, Kaushal S, Sperry M, Vigneault F, Gardner E, Loomba S, Shcherbina K, Keshari V, Dinis A, Vasan A, Chandrasekhar V, Takeda T, Nihalani R, Umur S, Turner JR, Levin M, Ingber DE.   +17 more
europepmc   +1 more source

A New Look at the Role of Radiation-Related Epigenetic Mechanisms in Diagnosis and Anticancer Therapies. [PDF]

Cells
Olichwier AJ, Bruzgo-Grzybko M, Kalita IS, Bielicka N, Chabielska E, Gromotowicz-Poplawska A.   +5 more
europepmc   +1 more source

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir. [PDF]

PLoS Pathog
Kim Y, Anderson JL, Tumpach C, Solomon A, Ong J, Tanaka K, Zerbato JM, Tan T, Teh CE, Gray DHD, Arandjelovic P, McMahon J, Meagher N, Price D, Pellegrini M, Roche M, Lewin SR.   +16 more
europepmc   +1 more source

Context-aware gene dependency modeling via graph attention networks for precision oncology. [PDF]

J Transl Med
Yu G, Gong Y, Fan B, Gao J, Fan Q.
europepmc   +1 more source

Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells. [PDF]

J Cell Mol Med
Topcu KSB, Cacan E.
europepmc   +1 more source

New drugs: Vorinostat

Australian Prescriber, 2014
openaire   +1 more source

Histone and non-histone (de)acetylation impact on the blood-brain barrier. [PDF]

Fluids Barriers CNS
Melo M, Fortuna A, Laranjinha J, Bicker J.   +3 more
europepmc   +1 more source

Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma. [PDF]

Front Oncol
Wang X, Wang X, Chen L, Ding H, Fan J, Liang J, Zhang Y, Li Y, Zhang Y, Yu S, Zhang C, Li Y, Li T, Yang X.   +13 more
europepmc   +1 more source

Targeting HDAC and PARP Enhances STING-Dependent Antitumor Immunity in STING-Deficient Tumor. [PDF]

Adv Sci (Weinh)
Mao C, Fan W, Liu J, Yang F, Li W, Li L, Shi Z, Li Q, Yuan Z, Jiang Y, Chu B.   +10 more
europepmc   +1 more source